IAFFALDANO, ANTONIO
IAFFALDANO, ANTONIO
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing
2024-01-01 Manni, A.; Oggiano, F.; Palazzo, C.; Panetta, V.; Gargano, C. D.; Mangialardi, V.; Guerra, T.; Iaffaldano, A.; Caputo, F.; Iaffaldano, P.; Ruggieri, M.; Trojano, M.; Paolicelli, D.
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
2020-01-01 Paolicelli, Damiano; Manni, Alessia; Iaffaldano, Antonio; Trojano, Maria
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort
2017-01-01 Manni, Alessia; Direnzo, Vita; Iaffaldano, Antonio; DI LECCE, Valentina; Tortorella, Carla; Zoccolella, Stefano; Iaffaldano, Pietro; Troiano, Maria; Paolicelli, Damiano
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort
2019-01-01 Manni, Alessia; Iaffaldano, A.; Lucisano, G.; D'Onghia, M.; Mezzapesa, D. M.; Felica, Vincenzo; Iaffaldano, P.; Trojano, M.; Paolicelli, D.
Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study
2023-01-01 Albano, Valeria; Dammacco, Rosanna; Manni, Alessia; Sisto, Dario; Iaffaldano, Antonio; Mavilio, Alberto; Alessio, Giovanni; Trojano, Maria; Paolicelli, Damiano
Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments
2018-01-01 Paolicelli, D.; Iaffaldano, A.; Manni, A.
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients
2022-01-01 Paolicelli, Damiano; Ruggieri, Maddalena; Manni, Alessia; Gargano, Concetta D; Carleo, Graziana; Palazzo, Claudia; Iaffaldano, Antonio; Bollo, Luca; Guerra, Tommaso; Saracino, Annalisa; Frigeri, Antonio; Iaffaldano, Pietro; Trojano, Maria
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register
2019-01-01 Paolicelli, D.; Lucisano, G.; Manni, A.; Avolio, C.; Bonavita, S.; Brescia Morra, V.; Capobianco, M.; Cocco, E.; Conte, A.; De Luca, G.; De Robertis, F.; Gasperini, C.; Gatto, M.; Gazzola, P.; Lus, G.; Iaffaldano, A.; Iaffaldano, P.; Maimone, D.; Mallucci, G.; Maniscalco, G. T.; Marfia, G. A.; Patti, F.; Pesci, I.; Pozzilli, C.; Rovaris, M.; Salemi, G.; Salvetti, M.; Spitaleri, D.; Totaro, R.; Zaffaroni, M.; Comi, G.; Amato, M. P.; Trojano, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing | 1-gen-2024 | Manni, A.; Oggiano, F.; Palazzo, C.; Panetta, V.; Gargano, C. D.; Mangialardi, V.; Guerra, T.; Iaffaldano, A.; Caputo, F.; Iaffaldano, P.; Ruggieri, M.; Trojano, M.; Paolicelli, D. | |
| Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis | 1-gen-2020 | Paolicelli, Damiano; Manni, Alessia; Iaffaldano, Antonio; Trojano, Maria | |
| Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort | 1-gen-2017 | Manni, Alessia; Direnzo, Vita; Iaffaldano, Antonio; DI LECCE, Valentina; Tortorella, Carla; Zoccolella, Stefano; Iaffaldano, Pietro; Troiano, Maria; Paolicelli, Damiano | |
| Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort | 1-gen-2019 | Manni, Alessia; Iaffaldano, A.; Lucisano, G.; D'Onghia, M.; Mezzapesa, D. M.; Felica, Vincenzo; Iaffaldano, P.; Trojano, M.; Paolicelli, D. | |
| Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study | 1-gen-2023 | Albano, Valeria; Dammacco, Rosanna; Manni, Alessia; Sisto, Dario; Iaffaldano, Antonio; Mavilio, Alberto; Alessio, Giovanni; Trojano, Maria; Paolicelli, Damiano | |
| Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments | 1-gen-2018 | Paolicelli, D.; Iaffaldano, A.; Manni, A. | |
| Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients | 1-gen-2022 | Paolicelli, Damiano; Ruggieri, Maddalena; Manni, Alessia; Gargano, Concetta D; Carleo, Graziana; Palazzo, Claudia; Iaffaldano, Antonio; Bollo, Luca; Guerra, Tommaso; Saracino, Annalisa; Frigeri, Antonio; Iaffaldano, Pietro; Trojano, Maria | |
| Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register | 1-gen-2019 | Paolicelli, D.; Lucisano, G.; Manni, A.; Avolio, C.; Bonavita, S.; Brescia Morra, V.; Capobianco, M.; Cocco, E.; Conte, A.; De Luca, G.; De Robertis, F.; Gasperini, C.; Gatto, M.; Gazzola, P.; Lus, G.; Iaffaldano, A.; Iaffaldano, P.; Maimone, D.; Mallucci, G.; Maniscalco, G. T.; Marfia, G. A.; Patti, F.; Pesci, I.; Pozzilli, C.; Rovaris, M.; Salemi, G.; Salvetti, M.; Spitaleri, D.; Totaro, R.; Zaffaroni, M.; Comi, G.; Amato, M. P.; Trojano, M. |